IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: Intraoperative neuromonitoring in Tennessee

In 2025 Q1–Q4, the provider or facility offer prevailed in 81.5% of 6,158 determined Federal IDR dispute line items for intraoperative neuromonitoring in Tennessee. The median prevailing offer was 19.49x the QPA (25th–75th percentile 7.27x–58.68x; n = 5,832). The median time to a decision was 31 business days (n = 6,158).

Determined line items

6,158

2025 Q1–Q4 · 2 split decisions excluded

Provider win rate

81.5%

n = 6,158 · 2025 Q1–Q4

Median payment vs QPA

19.49x

middle half 7.27x–58.68x · n = 5,832 · 2025 Q1–Q4

Median days to decision

31

business days, from dispute initiation · n = 6,158 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q46,15881.5%19.49x7.27x–58.68x5,83231
2024 Q1–Q42,79679.1%13.50x3.26x–52.62x2,62152
2023 Q1–Q433360.7%5.19x1.00x–12.62x19578
2023 Q1–2025 Q49,28780.0%17.20x5.19x–56.43x8,648not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
95938 Placement of skin electrodes and measurement of stimulated sites on arms and leg1,44982.3%31.84x †1,37832
95941 Continuous remote monitoring of nervous system during operation, each hour99683.9%12.43x95228
95939 Placement of skin electrodes and measurement of central motor stimulation in arm89381.7%18.62x84931
95861 Needle measurement of electrical activity in arm or leg muscles, 2 extremities81381.9%16.40x76530
95937 Testing of nerve-muscle junction55481.2%60.25x †53932
95955 Measurement of brain wave activity (EEG) outside the brain during surgery33184.0%18.02x30330
95870 Needle measurement of electrical activity in arm, leg, trunk or head muscles, li14377.6%9.25x13238
95886 Needle measurement of electrical activity in arm or leg muscles, complete study11072.7%8.23x11026
95868 Needle measurement of electrical activity in muscles on both sides of body6279.0%19.66x6025
95907 Nerve conduction, 1-2 studies5791.2%33.10x †5531
95867 Needle measurement of electrical activity in muscles on side of body3488.2%57.62x †3335
95908 Nerve conduction, 3-4 studies3482.4%6.30x3439.5
95940 Continuous monitoring of nervous system during operation, each 15 minutes3281.2%–2033

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Related: all specialties in Tennessee · Intraoperative neuromonitoring in all states

FAQ

What is the Federal IDR provider win rate for intraoperative neuromonitoring in Tennessee?

In 2025 Q1–Q4, the provider or facility offer was selected in 81.5% of 6,158 determined dispute line items for intraoperative neuromonitoring in Tennessee. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for intraoperative neuromonitoring in Tennessee?

In 2025 Q1–Q4, the median prevailing offer was 19.49x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 7.27x to 58.68x (n = 5,832 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for intraoperative neuromonitoring in Tennessee?

In 2025 Q1–Q4, the median was 31 business days (n = 6,158 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR